BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 779424)

  • 1. Immunotherapy of gliomas: a review.
    Ommaya AK
    Adv Neurol; 1976; 15():337-59. PubMed ID: 779424
    [No Abstract]   [Full Text] [Related]  

  • 2. [Active immunotherapy of cerebral tumor. 20 cases].
    Trouillas P; Lapras C
    Neurochirurgie; 1970; 16(2):143-70. PubMed ID: 4317954
    [No Abstract]   [Full Text] [Related]  

  • 3. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
    Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
    Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliomas: new ways of treatment?
    van Acker RE
    Clin Neurol Neurosurg; 1977; 80(2):112-5. PubMed ID: 209922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunotherapy of brain tumors].
    Takakura K; Watanabe T
    No Shinkei Geka; 1982 Dec; 10(12):1245-54. PubMed ID: 6188989
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring immune responses after glioma vaccine immunotherapy.
    Jian B; Yang I; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):195-9. PubMed ID: 19944978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy of malignant gliomas.
    Jaeckle KA
    Semin Oncol; 1994 Apr; 21(2):249-59. PubMed ID: 8153668
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neurosurgery and molecular biology: (series 12) immunological therapy for gliomas].
    Kijima H; Shimizu K
    No Shinkei Geka; 1999 Dec; 27(12):1071-7. PubMed ID: 10629887
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological aspects of intrinsic glial tumors.
    Apuzzo ML; Mitchell MS
    J Neurosurg; 1981 Jul; 55(1):1-18. PubMed ID: 7017079
    [No Abstract]   [Full Text] [Related]  

  • 11. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of experimental active specific immunotherapy and immunoprevention of malignant gliomas of the brain].
    Romodanov SA; Zatula DG; Lisianyĭ NI; Glavatskiĭ AIa; Prosvirneva GM
    Zh Vopr Neirokhir Im N N Burdenko; 1986; (3):18-23. PubMed ID: 3739492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.
    Plautz GE; Touhalisky JE; Shu S
    Cell Immunol; 1997 Jun; 178(2):101-7. PubMed ID: 9225000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
    Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
    Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogene therapy as a treatment for malignant brain tumors in young mice.
    Glick RP; Lichtor T; Lin H; Tarlock K; Cohen EP
    J Neurosurg; 2006 Jul; 105(1 Suppl):65-70. PubMed ID: 16871873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of local immunoresistance in glioma.
    Albesiano E; Han JE; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy for malignant gliomas (author's transl)].
    Ishizawa A
    Neurol Med Chir (Tokyo); 1981 Feb; 21(2):179-91. PubMed ID: 6164941
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of regulatory T cells in malignant glioma.
    Sonabend AM; Rolle CE; Lesniak MS
    Anticancer Res; 2008; 28(2B):1143-50. PubMed ID: 18505050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biologic basis of malignant brain tumor therapy.
    Kirsch WM; Van Buskirk JJ; Schulz DW; Tabuchi K
    Adv Neurol; 1976; 15():301-13. PubMed ID: 180778
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunobiology of human gliomas.
    Bullard DE; Gillespie GY; Mahaley MS; Bigner DD
    Semin Oncol; 1986 Mar; 13(1):94-109. PubMed ID: 2420011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.